Publications by authors named "Dirk Weber"

Claim this Profile
E
Exercise intensity determines circulating levels of Lac-Phe and other exerkines: a randomized crossover trial.
Dirk Weber, Paola G Ferrario, Achim Bub

Metabolomics· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multi-target gene therapy AUP1602-C to improve healing and quality of life for diabetic foot ulcer patients: a phase I, open-label, dose-finding study.
Christoph Schindler, Jacek Mikosiński, Pawel Mikosiński, Hanna-Riikka Kärkkäinen, Mirka Sanio, Dirk Weber

Ther Adv Endocrinol Metab· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Phase I Study of the Pan-Notch Inhibitor CB-103 for Patients with Advanced Adenoid Cystic Carcinoma and Other Tumors.
Glenn J Hanna, Anastasios Stathis, Elena Lopez-Miranda, Fabricio Racca, Doris Quon, Dirk Weber

Cancer Res Commun· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficient synthesis of Empagliflozin, an inhibitor of SGLT-2, utilizing an AlCl3-promoted silane reduction of a β-glycopyranoside.
Xiao-jun Wang, Li Zhang, Denis Byrne, Larry Nummy, Dirk Weber

Org Lett· August 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Randomized, open-label, phase III study comparing patupilone (EPO906) with pegylated liposomal doxorubicin in platinum-refractory or -resistant patients with recurrent epithelial ovarian, primary fallopian tube, or primary peritoneal cancer.
Nicoletta Colombo, Elzbieta Kutarska, Meletios Dimopoulos, Duk-Soo Bae, Izabella Rzepka-Gorska, Dirk Weber

J Clin Oncol· November 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patupilone (epothilone B) for recurrent glioblastoma: clinical outcome and translational analysis of a single-institution phase I/II trial.
Christoph Oehler, Karl Frei, Elisabeth J Rushing, Paul M J McSheehy, Dirk Weber

Oncology· October 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Conversion of self-assembled monolayers into nanocrystalline graphene: structure and electric transport.
Andrey Turchanin, Dirk Weber, Matthias Büenfeld, Christian Kisielowski, Mikhail V Fistul

ACS Nano· May 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Visualization of the electrical conductivity of freestanding nanowires.
Dirk H Weber, André Beyer, Berthold Völkel, Armin Gölzhäuser

Small· June 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Design of selective peptidomimetic agonists for the human orphan receptor BRS-3.
Dirk Weber, Claudia Berger, Peter Eickelmann, Jochen Antel, Horst Kessler

J Med Chem· May 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Vascular endothelial growth factor mediated angiogenic potential of pancreatic ductal carcinomas enhanced by hypoxia: an in vitro and in vivo study.
Bence Sipos, Dirk Weber, Hendrik Ungefroren, Holger Kalthoff, Andre Zühlsdorff

Int J Cancer· December 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Systematic optimization of a lead-structure identities for a selective short peptide agonist for the human orphan receptor BRS-3.
Dirk Weber, Claudia Berger, Timo Heinrich, Peter Eickelmann, Jochen Antel

J Pept Sci· August 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis